A recent study in Estonia reveals a significant disparity in mental healthcare, with patients being two to three times more likely to be prescribed medication, such as antidepressants, than to receive therapy for depression. This trend varies depending on the patient's age group, but consistently favors pharmaceutical intervention over talk therapy. The research highlights a potential gap in mental health services within Estonia, suggesting limited access to or prioritization of therapeutic options. Experts suggest this could be due to several factors, including the availability of mental health professionals and established healthcare practices. The study underscores the need to evaluate and potentially rebalance mental healthcare approaches in Estonia, ensuring patients have equitable access to both medication and therapy. Further investigation is needed to determine the long-term effects of this imbalance on patient well-being in Estonia.